Prevalence of renal and bone risk factors and nucleos(t)ide analogue treatment among patients with chronic hepatitis B in the United States.
Saved in:
| Title: | Prevalence of renal and bone risk factors and nucleos(t)ide analogue treatment among patients with chronic hepatitis B in the United States. |
|---|---|
| Authors: | Stead AE; Gilead Sciences, Inc., Foster City, CA., Christoph MJ; Gilead Sciences, Inc., Foster City, CA., Singer AW; Gilead Sciences, Inc., Foster City, CA., Wang W; Gilead Sciences, Inc., Foster City, CA., Hsiao A; Gilead Sciences, Inc., Foster City, CA., Majethia S; Gilead Sciences, Inc., Foster City, CA., Byrne S; Gilead Sciences, Inc., Foster City, CA., Zachry W; Gilead Sciences, Inc., Foster City, CA. |
| Source: | Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2026 Jul 09, pp. 1-13. Date of Electronic Publication: 2026 Jul 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2376-1032 |
|---|---|
| DOI: | 10.18553/jmcp.2026.26066 |
